AHEAD Clinical Trial Information Session

1070 Cranston Street,Cranston RI 02920

01 November, 2022

Description

The AHEAD Study is an exciting step in the fight against Alzheimer’s disease. The AHEAD Study tests whether an investigational treatment can slow or stop the earliest brain changes due to Alzheimer’s disease in people with a higher risk of developing the disease later in life. Brain changes related to Alzheimer’s disease can begin up to 20 years before a person notices any symptoms. Learn more about your risk and this groundbreaking study from researchers from the Memory and Aging Program. Questions about this information session? Call Memory and Aging Program Outreach Coordinator, Athena Lavoie, at 401-455-6402 or e-mail [email protected]